How do you know if a mast cell tumor is cancerous?

Table of Contents

Determining if a mast cell tumor is cancerous involves assessing its grade (based on cell appearance under a microscope) and its behavior (aggressiveness). This information, gained through biopsy and analysis, helps predict the tumor’s likelihood of spreading and impacting the patient’s health.

Understanding Mast Cell Tumors

Mast cell tumors (MCTs) are a common type of skin tumor, particularly in dogs, but they can also occur in cats and, rarely, in humans. They arise from mast cells, which are part of the immune system and contain substances like histamine that contribute to allergic reactions. When these cells become cancerous, they can form tumors that vary widely in their appearance and behavior. Understanding MCTs is crucial for effective diagnosis and treatment.

Appearance and Location of Mast Cell Tumors

MCTs can present in a variety of ways, making diagnosis challenging based on appearance alone. They can be:

Small or large
Raised or flat
Firm or soft
Located anywhere on the body

Common locations include the skin and subcutaneous tissue, but they can also occur internally. Their diverse presentation underscores the need for diagnostic testing.

Diagnostic Process: The Key to Knowing

How do you know if a mast cell tumor is cancerous? The diagnostic process involves several steps:

Cytology/Fine Needle Aspirate (FNA): A needle is used to collect cells from the tumor for microscopic examination. This can often provide a preliminary diagnosis.
Biopsy: A small piece of the tumor is surgically removed and sent to a veterinary pathologist for analysis. This is the gold standard for diagnosis and grading.
Histopathology (Microscopic Examination): The pathologist examines the tissue sample to determine the tumor grade, mitotic index (how quickly the cells are dividing), and whether the margins are clear (meaning the tumor has been completely removed).
Staging (if needed): Depending on the tumor grade and location, further tests may be recommended to determine if the cancer has spread (metastasized) to other parts of the body. These tests might include blood work, lymph node aspirates, abdominal ultrasound, and bone marrow aspirate.

Grading Systems: The Cancerous Yardstick

The grading of an MCT is a crucial factor in determining its cancerous potential. Two main grading systems are used:

Patnaik System (older, 3-tier system):
- Grade I: Well-differentiated, slow-growing, and less likely to metastasize.
- Grade II: Moderately differentiated, with an intermediate risk of metastasis.
- Grade III: Poorly differentiated, aggressive, and highly likely to metastasize.
Kiupel System (newer, 2-tier system): This system is now preferred by many veterinary pathologists due to its improved prognostic accuracy. Tumors are classified as either:
- Low Grade: Less aggressive, less likely to metastasize.
- High Grade: More aggressive, more likely to metastasize.

Additional Prognostic Factors

Beyond grading, other factors influence the prognosis of MCTs:

Mitotic Index: A higher mitotic index indicates faster cell division and a more aggressive tumor.
Location: Tumors in certain locations (e.g., mucocutaneous junctions, preputial region) tend to be more aggressive.
Completeness of Resection (Margins): If the surgical margins are not clear, meaning cancer cells are still present at the edge of the removed tissue, the tumor is more likely to recur.
c-KIT Mutation: Mutations in the c-KIT gene can increase tumor growth and make them more resistant to certain treatments.
Lymph Node Involvement: Metastasis to regional lymph nodes significantly worsens the prognosis.

Treatment Options Based on Cancerous Potential

Treatment options vary depending on the grade, location, and stage of the MCT:

Surgery: Surgical removal is the primary treatment for localized MCTs.
Radiation Therapy: Can be used to treat incompletely resected tumors or those in difficult-to-reach locations.
Chemotherapy: Used to treat metastatic disease or high-grade tumors.
Tyrosine Kinase Inhibitors (TKIs): Drugs like Toceranib and Masitinib can target the c-KIT mutation and inhibit tumor growth.
Steroids: Can help reduce inflammation and tumor size, but are not a long-term solution.

Frequently Asked Questions (FAQs)

How accurate is a fine needle aspirate (FNA) for diagnosing mast cell tumors?

FNA is generally highly accurate for diagnosing MCTs because mast cells are easily identifiable under a microscope. However, it cannot determine the tumor grade, which requires a biopsy. An FNA result will indicate that mast cells are present, but not necessarily if it is a low grade or high grade mast cell tumor.

What is the significance of “clear margins” after surgical removal of a mast cell tumor?

“Clear margins” mean that the pathologist did not find any cancer cells at the edge of the tissue sample removed during surgery. This indicates that the entire tumor was successfully removed, reducing the risk of recurrence. If margins are not clear, additional surgery, radiation, or other treatments may be necessary.

Can a mast cell tumor be benign?

While mast cell tumors are, by definition, cancerous neoplasms (abnormal growth), their behavior can range from relatively benign to highly aggressive. A low-grade MCT that is completely removed with clear margins may not require further treatment and may not recur, effectively acting as a benign tumor in its clinical course. The cancerous nature is assessed by the risk of metastasis and how aggressive it is, not necessarily if it is going to be fatal.

What are the common signs of metastasis in mast cell tumors?

Signs of metastasis can include enlarged lymph nodes near the tumor, loss of appetite, weight loss, vomiting, diarrhea, and lethargy. Internal organ involvement can lead to a variety of other symptoms.

What is the prognosis for dogs with mast cell tumors?

The prognosis varies widely depending on the tumor grade, location, stage, and treatment received. Dogs with low-grade tumors that are completely removed have a good prognosis, while those with high-grade, metastatic tumors have a poorer prognosis.

Are certain breeds of dogs more prone to developing mast cell tumors?

Yes, certain breeds are predisposed to MCTs, including Boxers, Boston Terriers, Bulldogs, Labrador Retrievers, and Golden Retrievers. However, any breed can develop these tumors.

What role does c-KIT mutation play in mast cell tumors?

Mutations in the c-KIT gene can cause mast cells to proliferate uncontrollably, leading to tumor formation. These mutations can also make the tumors more resistant to certain chemotherapy drugs. Therefore, it is important to know if the tumor has a c-KIT mutation, which is done through a test.

How do tyrosine kinase inhibitors (TKIs) work in treating mast cell tumors?

TKIs, such as toceranib and masitinib, target and inhibit the activity of the c-KIT protein, which is often overactive or mutated in MCTs. This can help slow down tumor growth and improve survival times.

Is there a cure for mast cell tumors?

A complete surgical removal of a low grade mast cell tumor is considered a “cure” in that no further treatment may be needed and the chances of recurrence are low. For aggressive tumors, surgery can’t “cure” the patient. Therefore, there is no one cure for mast cell tumors; the treatment options depend on the individual case.

What are the potential side effects of treatment for mast cell tumors?

Side effects can vary depending on the treatment used. Surgery can lead to infection or wound dehiscence. Radiation therapy can cause skin irritation and other local effects. Chemotherapy and TKIs can cause gastrointestinal upset, bone marrow suppression, and other systemic side effects.

How important is staging for mast cell tumors?

Staging is crucial because it helps determine the extent of the disease and guide treatment decisions. It involves assessing whether the tumor has spread to regional lymph nodes or distant organs, which significantly impacts the prognosis.

What can I do to prevent mast cell tumors in my pet?

Unfortunately, there is no known way to prevent MCTs. Regular veterinary checkups and prompt attention to any new skin masses are the best ways to detect and treat these tumors early. Early detection significantly improves the chances of successful treatment.

How do you know if a mast cell tumor is cancerous? It’s a combination of factors assessed by your veterinarian, including tumor grade, mitotic index, location, and presence of metastasis, along with overall clinical signs.